Publications by authors named "Markus Puhlmann"

Claim this Profile
R
Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2.
Kerry J Savage, Steven M Horwitz, Ranjana Advani, Jacob Haaber Christensen, Eva Domingo-Domenech, Markus Puhlmann

Blood Adv· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma.
Stephen M Ansell, John Radford, Joseph M Connors, Monika Długosz-Danecka, Won-Seog Kim, Markus Puhlmann

N Engl J Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney: a randomized, double-blind, placebo-controlled, phase 2 study.
Brian Rini, Cezary Szczylik, Nizar M Tannir, Piotr Koralewski, Piotr Tomczak, Markus Puhlmann

Cancer· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct evidence for rapid and selective induction of tumor neovascular permeability by tumor necrosis factor and a novel derivative, colloidal gold bound tumor necrosis factor.
Jeffrey M Farma, Markus Puhlmann, Perry A Soriano, Derrick Cox, Giulio F Paciotti

Int J Cancer· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of interleukin 1 in growth and metastasis of human cancer xenografts.
Dina M Elaraj, David M Weinreich, Sheelu Varghese, Markus Puhlmann, Stephen M Hewitt

Clin Cancer Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-1beta induced vascular permeability is dependent on induction of endothelial tissue factor (TF) activity.
Markus Puhlmann, David M Weinreich, Jeffrey M Farma, Nancy M Carroll, Ewa M Turner

J Transl Med· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in tumor necrosis factor-induced endothelial cell procoagulant activity by hyperthermia.
Nancy M Carroll, Dina M Elaraj, Markus Puhlmann, David M Weinreich, Ewa M Turner

Int J Cancer· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.
David M Weinreich, Dina M Elaraj, Markus Puhlmann, Stephen M Hewitt, Nancy M Carroll

Cancer Res· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF.
Josef Friedl, Markus Puhlmann, David L Bartlett, Steven K Libutti, Ewa N Turner

Blood· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration.
Monica C Panelli, Ena Wang, Giao Phan, Markus Puhlmann, Lance Miller

Genome Biol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis